skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Cancer remover assunto: Metastasis remover tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors

PR Newswire, 2023

New York: PR Newswire Association LLC

Sem texto completo

2
Reports Outline Prostate Cancer Study Results from Icahn School of Medicine at Mount Sinai (Characterizing Prostate-specific Antigen Levels At Death In Patients With Metastatic Castration-resistant Prostate Cancer: Are We Underutilizing Imaging?)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço
3
Oncology - Cancer; Missing-In-Metastasis / Metastasis Suppressor 1 modulates B cell receptor signaling, B cell metabolic potential and T cell-independent immune responses
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Oncology - Cancer; Missing-In-Metastasis / Metastasis Suppressor 1 modulates B cell receptor signaling, B cell metabolic potential and T cell-independent immune responses

Vaccine Weekly, 2020, p.40

Atlanta: NewsRx

Texto completo disponível

4
Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors

Immunotherapy Weekly, 2023, p.1178

NewsRX LLC

Texto completo disponível

5
Researchers at National Institute of Oncology Detail Findings in Melanoma (Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço
6
Cancer; New Cancer Findings from University of Shandong Reported (A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Cancer; New Cancer Findings from University of Shandong Reported (A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth)

Drug Week, 2019, p.2190

Atlanta: NewsRx

Texto completo disponível

7
Researcher at University of Texas MD Anderson Cancer Center Zeroes in on Metastatic Cancer
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Researcher at University of Texas MD Anderson Cancer Center Zeroes in on Metastatic Cancer

Cancer Weekly, 2023, p.410

NewsRX LLC

Texto completo disponível

8
University Hospital of Tubingen Researchers Update Understanding of Melanoma (Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

University Hospital of Tubingen Researchers Update Understanding of Melanoma (Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report)

Immunotherapy Weekly, 2023, p.6757

NewsRX LLC

Texto completo disponível

9
Cancer; Recent Findings from University of Nebraska Medical Center Provide New Insights into Cancer (Cancer-associated mucins: role in immune modulation and metastasis)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Cancer; Recent Findings from University of Nebraska Medical Center Provide New Insights into Cancer (Cancer-associated mucins: role in immune modulation and metastasis)

Drug Week, 2019, p.3411

Atlanta: NewsRx

Texto completo disponível

10
Study Results from Memorial Sloan-Kettering Cancer Center Broaden Understanding of Synovial Sarcoma (Hla Genotyping In Synovial Sarcoma: Identifying Hla-a02 and Its Association With Clinical Outcome)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Study Results from Memorial Sloan-Kettering Cancer Center Broaden Understanding of Synovial Sarcoma (Hla Genotyping In Synovial Sarcoma: Identifying Hla-a02 and Its Association With Clinical Outcome)

Politics & Government Week, 2020, p.393

NewsRX LLC

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (449)

Data de Publicação 

De até
  1. Antes de2007  (105)
  2. 2007Até2010  (46)
  3. 2011Até2015  (21)
  4. 2016Até2020  (235)
  5. Após 2020  (78)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.